[Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection]. 1996

J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
Debreceni Orvostudományi Egyetem I. Belklinika.

The authors report the case of a 38 year old man with horseshoe kidney who developed a severe nephroso-nephritis syndrome, caused by cryoglobulinemic membranoproliferative glomerulo-nephritis. A combination of steroid and cyclophosphamide treatment resulted in partial improvement, but was discontinued after 12 weeks due to adverse reactions, with a consequent early relapse. The 4 week course of cyclosporine monotherapy proved ineffective and signs of cryoglobulinemia appeared. The elevation of transaminase, manifested during the immunosuppressive therapy demonstrated the presence of underlying chronic C hepatitis. In the light of the liver biopsy result, interferon treatment was commenced at a dose of 3 million unit thrice weekly. After 4 months of interferon treatment the persistent nephrotic range proteinuria decreased to below 0.5 g/day. Four months later clinical signs of cryoglobulinemia disappeared, and after the 10th month of interferon treatment no cryoglobulin could be detected in the patient's sera. After one year, the interferon treatment was discontinued following a negative PCR result for HCV. However, one month later the proteinuria increased and the quantitative hepatitis C virus nucleic acid test in sera became positive again. Our case demonstrates that interferon therapy may be effective in the treatment of cryoglobulinemic glomerulonephritis responding poorly to the immunosuppressive therapy, though larger doses or longer periods of treatment may be required to prevent relapses.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
January 1997, Orvosi hetilap,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
January 1993, American journal of nephrology,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
February 2018, Clinical case reports,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
May 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
March 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
December 1993, Journal of the American Society of Nephrology : JASN,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
February 1993, The New England journal of medicine,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
January 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
December 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Mátyus, and J Kovács, and L Ujhelyi, and I Kárpáti, and L Dalmi, and G Kakuk
March 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Copied contents to your clipboard!